138 related articles for article (PubMed ID: 29208006)
21. Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.
Lovisolo JA; Casati B; Clerici L; Marafante E; Bono AV; Celato N; Salvadore M
BJU Int; 2006 Jul; 98(1):205-16. PubMed ID: 16831170
[TBL] [Abstract][Full Text] [Related]
22. Classification of renal neoplasms based on molecular signatures.
Yang XJ; Sugimura J; Schafernak KT; Tretiakova MS; Han M; Vogelzang NJ; Furge K; Teh BT
J Urol; 2006 Jun; 175(6):2302-6. PubMed ID: 16697863
[TBL] [Abstract][Full Text] [Related]
23. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis.
Gonzalgo ML; Yegnasubramanian S; Yan G; Rogers CG; Nicol TL; Nelson WG; Pavlovich CP
Clin Cancer Res; 2004 Nov; 10(21):7276-83. PubMed ID: 15534102
[TBL] [Abstract][Full Text] [Related]
24. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
Li P; Conley A; Zhang H; Kim HL
BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
[TBL] [Abstract][Full Text] [Related]
25. A genomic algorithm for the molecular classification of common renal cortical neoplasms: development and validation.
Gowrishankar B; Przybycin CG; Ma C; Nandula SV; Rini B; Campbell S; Klein E; Chaganti RS; Magi-Galluzzi C; Houldsworth J
J Urol; 2015 May; 193(5):1479-85. PubMed ID: 25498568
[TBL] [Abstract][Full Text] [Related]
26. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
27. Microarray gene expression profiling and analysis in renal cell carcinoma.
Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of an eight-gene expression signature for predicting high Fuhrman grade renal cell carcinoma.
Wan F; Zhu Y; Han C; Xu Q; Wu J; Dai B; Zhang H; Shi G; Gu W; Ye D
Int J Cancer; 2017 Mar; 140(5):1199-1208. PubMed ID: 27874173
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens.
Weng L; Wu X; Gao H; Mu B; Li X; Wang JH; Guo C; Jin JM; Chen Z; Covarrubias M; Yuan YC; Weiss LM; Wu H
J Pathol; 2010 Sep; 222(1):41-51. PubMed ID: 20593407
[TBL] [Abstract][Full Text] [Related]
30. A multigene assay identifying distinct prognostic subtypes of clear cell renal cell carcinoma with differential response to tyrosine kinase inhibition.
Choudhury Y; Wei X; Chu YH; Ng LG; Tan HS; Koh V; Thike AA; Poon E; Ng QS; Toh CK; Kanesvaran R; Tan PH; Tan MH
Eur Urol; 2015 Jan; 67(1):17-20. PubMed ID: 25018036
[TBL] [Abstract][Full Text] [Related]
31. [Genomic classification of renal cell tumors in adults].
Couturier J
Ann Pathol; 2008 Oct; 28(5):402-8. PubMed ID: 19068394
[TBL] [Abstract][Full Text] [Related]
32. DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
Malouf GG; Su X; Zhang J; Creighton CJ; Ho TH; Lu Y; Raynal NJ; Karam JA; Tamboli P; Allanick F; Mouawad R; Spano JP; Khayat D; Wood CG; Jelinek J; Tannir NM
Clin Cancer Res; 2016 Dec; 22(24):6236-6246. PubMed ID: 27256309
[TBL] [Abstract][Full Text] [Related]
33. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.
Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR
BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369
[TBL] [Abstract][Full Text] [Related]
34. A molecular classification of papillary renal cell carcinoma.
Yang XJ; Tan MH; Kim HL; Ditlev JA; Betten MW; Png CE; Kort EJ; Futami K; Furge KA; Takahashi M; Kanayama HO; Tan PH; Teh BS; Luan C; Wang K; Pins M; Tretiakova M; Anema J; Kahnoski R; Nicol T; Stadler W; Vogelzang NG; Amato R; Seligson D; Figlin R; Belldegrun A; Rogers CG; Teh BT
Cancer Res; 2005 Jul; 65(13):5628-37. PubMed ID: 15994935
[TBL] [Abstract][Full Text] [Related]
35. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
[TBL] [Abstract][Full Text] [Related]
36. Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
Ning XH; Gong YQ; He SM; Li T; Wang JY; Peng SH; Chen JC; Liu JY; Qi NN; Guo YL; Gong K
Oncotarget; 2017 Jan; 8(2):3355-3363. PubMed ID: 27926518
[TBL] [Abstract][Full Text] [Related]
37. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
38. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
[TBL] [Abstract][Full Text] [Related]
39. Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data Sets.
Faruki H; Mayhew GM; Fan C; Wilkerson MD; Parker S; Kam-Morgan L; Eisenberg M; Horten B; Hayes DN; Perou CM; Lai-Goldman M
Arch Pathol Lab Med; 2016 Jun; 140(6):536-42. PubMed ID: 26430809
[TBL] [Abstract][Full Text] [Related]
40. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
